🚧 Im Aufbau — Daten können ungenau sein. Wir fügen laufend weitere Unternehmen und Kennzahlen hinzu.
Sanofi logo

Sanofi

SAN.PARang #165GesundheitswesenArzneimittelhersteller – Allgemein

Marktkapitalisierung

$99.2B

Globaler Rang

#165

Allzeithoch

$109.9B

2024-12-31

Gesamtwachstum

+0%

seit 2026

Market Cap Context

$50.2B revenue · $10.3B operating income · $8.4B net income

  • Operating margin: 20.5% on $50.2B in revenue.
  • R&D is 16.8% of revenue ($8.4B).
  • Net income margin: 16.7% — $8.4B in profit.
  • Free cash flow: $7.8B (15.4% of revenue).

Cost / Operating Expenses

Total operating expenses $39.9B

Total

$33.5B

Cost of revenue· Product / service delivery costs (COGS)$14.0B41.9%
Research & development$8.4B25.2%
Sales & marketing$0.8B2.2%
General & administrative$10.3B30.7%

Capital Expenditures

$3.8B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$7.8B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

Über Sanofi

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.

Verlauf der Marktkapitalisierung von Sanofi (20262026)

Sanofi vs Sector Peers by Market Cap

Vertex Pharmaceuticals IncorporatedVRTX
$130.6B
Stryker CorporationSYK
$127.2B
SanofiSAN.PA
$99.2B
HCA Healthcare, Inc.HCA
$89.8B
Elevance Health, Inc.ELV
$84.6B
Regeneron Pharmaceuticals, Inc.REGN
$81.5B
Boston Scientific CorporationBSX
$74.5B
The Cigna GroupCI
$72.8B

Sanofi vergleichen

Rangverlauf

JahrMarktkapitalisierungRangVeränderung ggü. Vorjahr
2026$99.2B#165(17)-2.0%
2025$101.3B#148(25)-7.9%
2024$109.9B#123(12)+8.8%
2023$101.1B#111(14)+3.6%
2022$97.5B#97(12)+5.5%
2021$92.4B#109(1)+16.9%
2020$79.1B#108(30)-9.0%
2019$86.8B#78(8)+23.4%
2018$70.3B#70(16)+10.4%
2017$63.7B#86(29)-3.5%
2016$66.0B#57(1)+2.0%
2015$64.7B#56(3)+7.2%
2014$60.3B#59(6)+1.8%
2013$59.3B#53(12)+11.6%
2012$53.1B#41(8)+31.8%
2011$40.3B#49(16)+24.1%
2010$32.5B#65(14)-8.7%
2009$35.6B#51(5)+27.9%
2008$27.8B#46(10)-24.7%
2007$36.9B#56(15)-7.6%
2006$39.9B#41(10)-3.0%
2005$41.2B#31(3)+28.5%
2004$32.0B#34+1.5%
2003$31.6B#34(6)+4.1%
2002$30.3B#28(6)-29.8%
2001$43.2B#22(18)+18.8%
2000$36.3B#40

Weitere Unternehmen im Sektor Gesundheitswesen

FAQ

What is Sanofi's market cap?

Sanofi (SAN.PA) has a market capitalization of $99.2B, making it the #165 largest company in the world by market cap.

What was Sanofi's highest market cap?

Sanofi's all-time high market cap was $109.9B, reached in 2024-12-31. Its highest rank was #123 in 2024.

What sector is Sanofi in?

Sanofi is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in France.

How has Sanofi's market cap changed over time?

Sanofi has been tracked since 2026. Its market cap has grown by 0% from $99.2B in 2026 to $99.2B today.